Application of New Radiosensitizer Based on Nano-Biotechnology in the Treatment of Glioma

Overview

Journal Front Oncol

Specialty Oncology

Date 2021 Apr 19

PMID 33869019

Citations 7

Authors

Yandong Xie

Yuhan Han

Xuefeng Zhang

Hongwei Ma

Linfeng Li

Rutong Yu

Hongmei Liu

Affiliations

Soon will be listed here.

Abstract

Glioma is the most common intracranial malignant tumor, and its specific pathogenesis has been unclear, which has always been an unresolved clinical problem due to the limited therapeutic window of glioma. As we all know, surgical resection, chemotherapy, and radiotherapy are the main treatment methods for glioma. With the development of clinical trials and traditional treatment techniques, radiotherapy for glioma has increasingly exposed defects in the treatment effect. In order to improve the bottleneck of radiotherapy for glioma, people have done a lot of work; among this, nano-radiosensitizers have offered a novel and potential treatment method. Compared with conventional radiotherapy, nanotechnology can overcome the blood-brain barrier and improve the sensitivity of glioma to radiotherapy. This paper focuses on the research progress of nano-radiosensitizers in radiotherapy for glioma.

Citing Articles

Application of Multifunctional Metal Nanoparticles in the Treatment of Glioma.

Ren Y, Yang H, Xu D, Zhang Z, Gao S, Yu R Int J Nanomedicine. 2025; 20():625-638.

PMID: 39839457 PMC: 11748046. DOI: 10.2147/IJN.S493565.

Increasing the radiation-induced cytotoxicity by silver nanoparticles and docetaxel in prostate cancer cells.

Hatami Zharabad S, Mohammadian M, Zohdi Aghdam R, Hassanzadeh Dizaj M, Behrouzkia Z Mol Biol Rep. 2024; 51(1):633.

PMID: 38724835 DOI: 10.1007/s11033-024-09506-5.

Electrospun Drug-Loaded and Gene-Loaded Nanofibres: The Holy Grail of Glioblastoma Therapy?.

Louis L, Chee B, McAfee M, Nugent M Pharmaceutics. 2023; 15(6).

PMID: 37376095 PMC: 10302184. DOI: 10.3390/pharmaceutics15061649.

Application of nano-radiosensitizers in combination cancer therapy.

Varzandeh M, Sabouri L, Mansouri V, Gharibshahian M, Beheshtizadeh N, Hamblin M Bioeng Transl Med. 2023; 8(3):e10498.

PMID: 37206240 PMC: 10189501. DOI: 10.1002/btm2.10498.

Recent progress of hydrogel-based local drug delivery systems for postoperative radiotherapy.

Xie Y, Liu M, Cai C, Ye C, Guo T, Yang K Front Oncol. 2023; 13:1027254.

PMID: 36860309 PMC: 9969147. DOI: 10.3389/fonc.2023.1027254.

References

Liu P, Huang Z, Chen Z, Xu R, Wu H, Zang F . Silver nanoparticles: a novel radiation sensitizer for glioma?. Nanoscale. 2013; 5(23):11829-36. DOI: 10.1039/c3nr01351k. View

Jung H, Rajasekaran N, Song S, Kim Y, Hong S, Choi H . Human Papillomavirus E6/E7-Specific siRNA Potentiates the Effect of Radiotherapy for Cervical Cancer in Vitro and in Vivo. Int J Mol Sci. 2015; 16(6):12243-60. PMC: 4490442. DOI: 10.3390/ijms160612243. View

Davila E, Klein L, Vogel C, Johnson R, Ostroy F, Browning S . Phase I trial of misonidazole (NSC#261037) plus cyclophosphamide in solid tumors. J Clin Oncol. 1985; 3(1):121-7. DOI: 10.1200/JCO.1985.3.1.121. View

Choi J, Kim G, Cho S, Im H . Radiosensitizing high-Z metal nanoparticles for enhanced radiotherapy of glioblastoma multiforme. J Nanobiotechnology. 2020; 18(1):122. PMC: 7470617. DOI: 10.1186/s12951-020-00684-5. View

Kumari A, Yadav S, Yadav S . Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B Biointerfaces. 2009; 75(1):1-18. DOI: 10.1016/j.colsurfb.2009.09.001. View

Peng C, Liang Y, Chen Y, Qian X, Luo W, Chen S . Hollow Mesoporous Tantalum Oxide Based Nanospheres for Triple Sensitization of Radiotherapy. ACS Appl Mater Interfaces. 2020; 12(5):5520-5530. DOI: 10.1021/acsami.9b20053. View

Abbott N, Patabendige A, Dolman D, Yusof S, Begley D . Structure and function of the blood-brain barrier. Neurobiol Dis. 2009; 37(1):13-25. DOI: 10.1016/j.nbd.2009.07.030. View

McMahon S, Paganetti H, Prise K . Optimising element choice for nanoparticle radiosensitisers. Nanoscale. 2015; 8(1):581-9. DOI: 10.1039/c5nr07089a. View

Wank M, Schilling D, Schmid T, Meyer B, Gempt J, Barz M . Human Glioma Migration and Infiltration Properties as a Target for Personalized Radiation Medicine. Cancers (Basel). 2018; 10(11). PMC: 6266328. DOI: 10.3390/cancers10110456. View

10.

Song G, Liang C, Yi X, Zhao Q, Cheng L, Yang K . Perfluorocarbon-Loaded Hollow Bi2Se3 Nanoparticles for Timely Supply of Oxygen under Near-Infrared Light to Enhance the Radiotherapy of Cancer. Adv Mater. 2016; 28(14):2716-23. DOI: 10.1002/adma.201504617. View

11.

Feng L, Dong Z, Liang C, Chen M, Tao D, Cheng L . Iridium nanocrystals encapsulated liposomes as near-infrared light controllable nanozymes for enhanced cancer radiotherapy. Biomaterials. 2018; 181:81-91. DOI: 10.1016/j.biomaterials.2018.07.049. View

12.

Hernandez-Rivera M, Kumar I, Cho S, Cheong B, Pulikkathara M, Moghaddam S . High-Performance Hybrid Bismuth-Carbon Nanotube Based Contrast Agent for X-ray CT Imaging. ACS Appl Mater Interfaces. 2017; 9(7):5709-5716. DOI: 10.1021/acsami.6b12768. View

13.

Song G, Cheng L, Chao Y, Yang K, Liu Z . Emerging Nanotechnology and Advanced Materials for Cancer Radiation Therapy. Adv Mater. 2017; 29(32). DOI: 10.1002/adma.201700996. View

14.

Tano T, Okamoto M, Kan S, Bando T, Goda H, Nakashiro K . Immunochemoradiotherapy for patients with oral squamous cell carcinoma: augmentation of OK-432-induced helper T cell 1 response by 5-FU and X-ray irradiation. Neoplasia. 2013; 15(7):805-14. PMC: 3689243. DOI: 10.1593/neo.13488. View

15.

Masunaga S, Uto Y, Nagasawa H, Hori H, Nagata K, Suzuki M . Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells. Anticancer Res. 2006; 26(2A):1261-70. View

16.

Paw I, Carpenter R, Watabe K, Debinski W, Lo H . Mechanisms regulating glioma invasion. Cancer Lett. 2015; 362(1):1-7. PMC: 4435977. DOI: 10.1016/j.canlet.2015.03.015. View

17.

de Sousa Cavalcante L, Monteiro G . Gemcitabine: metabolism and molecular mechanisms of action, sensitivity and chemoresistance in pancreatic cancer. Eur J Pharmacol. 2014; 741:8-16. DOI: 10.1016/j.ejphar.2014.07.041. View

18.

Liu Y, Chen W, Zhang P, Jin X, Liu X, Li P . Dynamically-enhanced retention of gold nanoclusters in HeLa cells following X-rays exposure: A cell cycle phase-dependent targeting approach. Radiother Oncol. 2016; 119(3):544-51. DOI: 10.1016/j.radonc.2016.04.033. View

19.

Chan L, Gao P, Zhou W, Mei C, Huang Y, Yu X . Sequentially Triggered Delivery System of Black Phosphorus Quantum Dots with Surface Charge-Switching Ability for Precise Tumor Radiosensitization. ACS Nano. 2018; 12(12):12401-12415. DOI: 10.1021/acsnano.8b06483. View

20.

Cheng Y, Zhu J, Zhao L, Xiong Z, Tang Y, Liu C . (131)I-labeled multifunctional dendrimers modified with BmK CT for targeted SPECT imaging and radiotherapy of gliomas. Nanomedicine (Lond). 2016; 11(10):1253-66. DOI: 10.2217/nnm-2016-0001. View